Key Findings
The North America autotransfusion devices and consumables market is expected to flourish with a CAGR of 5.83% between 2019 and 2027. The North American market is estimated to capture XX% share by the end of the forecast period. The market is witnessing growth due to rising technological developments in the region. Autotransfusion is a process of blood transfusion used during surgeries, in which the patient’s blood is extracted, then, filtered and purified before infusing back into the patient’s body.

Market Insights
The autotransfusion devices and consumables market in North America is studied over economies like the United States and Canada. In Canada, the rising incidences of renal and cardiovascular diseases together with the high disposable income of people is providing a lucrative market for the autotransfusion devices and consumables in the country. Further, the increasing focus on improving the quality of life, along with the usage of modern technologies is assisting the growth of autotransfusion devices and consumables market. However, lack of availability of donor and histocompatibility pose as challenges for the autotransfusion devices and consumables, thereby limiting market growth.

Competitive Insights
B. Braun Melsungen AG, Brightwake Ltd., Becton, Dickinson and Company (C.R. Bard), Asahi Kasei Corp., and Biegler GmbH, among others, are some of the dominant companies of the autotransfusion devices and consumables market. The eminent players focus on strategies like mergers & acquisition, product development, corporate expansions, agreements, and others.